glp 1 drug side effects Managing of GLP-1 Receptor Agonists – Transformation Weight Control Ozempic and other GLP-1 drugs
Description
PERK, PKR-like ER kinase
Biochem Pharmacol 164:3444 Pereira M, Jeyabalan J, Jorgensen CS, Hopkinson M, Al-Jazzar A, Roux JP, Chavassieux P, Orriss IR, Cleasby ME, Chenu C (2015) Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice
[DOI] [PubMed] [Google Scholar] 112
16637, Aug
miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function
Biochem Biophys Res Commun (2019) 510(1):206
